Rasch-analysis of Clinical Severity in FSHD



Status:Completed
Conditions:Neurology
Therapuetic Areas:Neurology
Healthy:No
Age Range:18 - Any
Updated:4/17/2018
Start Date:March 2016
End Date:April 18, 2017

Use our guide to learn which trials are right for you!

The purpose of this study is to make a standardized and scalable Rasch-built clinical
severity scale to help in finding genetic and environmental modifiers of disease in
Facioscapulohumeral muscular dystrophy (FSHD).


Inclusion Criteria:

- Genetic confirmation of FSHD (either FSHD-1 or FSHD-2)

Exclusion Criteria:

- Do not understand English

- Unable to provide informed consent
We found this trial at
2
sites
3901 Rainbow Blvd
Kansas City, Kansas 66160
(913) 588-5000
University of Kansas Medical Center The University of Kansas Medical Center serves Kansas through excellence...
?
mi
from
Kansas City, KS
Click here to add this to my saved trials
201 Presidents Circle
Salt Lake City, Utah 84108
801) 581-7200
University of Utah Research is a major component in the life of the U benefiting...
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials